English

COMPLETE GENOMICS INC

EDGAR

GNOM Quarterly report (10-Q) · filed 2012-11-09

12 filing records in this dataset, filed from 2010-07-30 to 2012-11-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

7.28 million USD

2012 Q3 · USD

Exact inputs and evidence

Revenue: 7276000 USD Source

Operating margin

-237.99%

2012 Q3 · %

Exact inputs and evidence

Operating Income: -17316000 USD Source
Revenue: 7276000 USD Source

Operating cash flow

-11.1 million USD

2012 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -43259000 USD Source
Operating Cash Flow: -32203000 USD Source

Free cash flow

-12.6 million USD

2012 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -43259000 USD Source
Operating Cash Flow: -32203000 USD Source
Capital Expenditure: 8944000 USD Source
Capital Expenditure: 7443000 USD Source

Cash and cash equivalents: 34.7 million USD 2012-09-30 Source
Exact value

34715000 USD
Long-term debt including current maturities: 22.5 million USD 2012-09-30 Source
Exact value

22542000 USD
Shares outstanding: 34.5 million shares 2012-09-30 Source
Exact value

34457289 shares

Reported share-count change

4.10% · 1.36 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

33100920 shares · 2011-09-30· Source
34457289 shares · 2012-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

22.3 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Revenue: 19344000 USD · 2011-01-01 – 2011-12-31 Source
Revenue: 16875000 USD · 2011-01-01 – 2011-09-30 Source
Revenue: 3908000 USD · 2012-01-01 – 2012-03-31 Source
Revenue: 8693000 USD · 2012-04-01 – 2012-06-30 Source
Revenue: 7276000 USD · 2012-07-01 – 2012-09-30 Source

Net income

-79.4 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Net income: -72348000 USD · 2011-01-01 – 2011-12-31 Source
Net income: -50026000 USD · 2011-01-01 – 2011-09-30 Source
Net income: -20232000 USD · 2012-01-01 – 2012-03-31 Source
Net income: -18827000 USD · 2012-04-01 – 2012-06-30 Source
Net income: -17989000 USD · 2012-07-01 – 2012-09-30 Source

Operating cash flow

-60.4 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Operating cash flow: -50511000 USD · 2011-01-01 – 2011-12-31 Source
Operating cash flow: -33377000 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: -15355000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -32203000 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -15355000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -43259000 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -32203000 USD · 2012-01-01 – 2012-06-30 Source

Capital expenditure

13.8 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Capital expenditure: 20395000 USD · 2011-01-01 – 2011-12-31 Source
Capital expenditure: 15563000 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 4804000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 7443000 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 4804000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 8944000 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 7443000 USD · 2012-01-01 – 2012-06-30 Source

Free cash flow

-74.2 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Operating cash flow: -50511000 USD · 2011-01-01 – 2011-12-31 Source
Operating cash flow: -33377000 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: -15355000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -32203000 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -15355000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -43259000 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -32203000 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 20395000 USD · 2011-01-01 – 2011-12-31 Source
Capital expenditure: 15563000 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 4804000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 7443000 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 4804000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 8944000 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 7443000 USD · 2012-01-01 – 2012-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-11-09.

Financial data available through: 2011-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2011-12-31
Operating income: 4 of 11 periods available· newest 2011-12-31
Net income: 4 of 11 periods available· newest 2011-12-31
Operating cash flow: 4 of 11 periods available· newest 2011-12-31
Capital expenditure: 4 of 11 periods available· newest 2011-12-31
Total assets: 3 of 11 periods available· newest 2011-12-31
Total liabilities: 3 of 11 periods available· newest 2011-12-31
Current assets: 3 of 11 periods available· newest 2011-12-31
Current liabilities: 3 of 11 periods available· newest 2011-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2011-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+106%

Prior period

USD 9.39 million

2010-01-01 – 2010-12-31
Current period

USD 19.34 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

19344000 − 9389000 = 9955000 USD

9389000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
19344000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · COMPLETE GENOMICS INC · 2011-12-31 COMPLETE GENOMICS INC (edgar:1361103) Year-over-year change in Revenue: 9955000 USD Concept: fundies:Revenue Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 19344000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#76607 Filing: 000119312512104641 Input fundies:Revenue: 9389000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#29346 Filing: 000119312512104641
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 14.66 million

Prior period

−USD 57.69 million

2010-01-01 – 2010-12-31
Current period

−USD 72.35 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-72348000 − -57687000 = -14661000 USD

-57687000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-72348000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · COMPLETE GENOMICS INC · 2011-12-31 COMPLETE GENOMICS INC (edgar:1361103) Year-over-year change in Net income: -14661000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -72348000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#177201 Filing: 000119312512104641 Input fundies:NetIncome: -57687000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#31499 Filing: 000119312512104641
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 15.49 million

Prior period

−USD 35.02 million

2010-01-01 – 2010-12-31
Current period

−USD 50.51 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-50511000 − -35018000 = -15493000 USD

-35018000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-50511000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · COMPLETE GENOMICS INC · 2011-12-31 COMPLETE GENOMICS INC (edgar:1361103) Year-over-year change in Operating cash flow: -15493000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -50511000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#135413 Filing: 000119312512104641 Input fundies:OperatingCashFlow: -35018000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#29643 Filing: 000119312512104641
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+8.5%

Prior period

USD 18.8 million

2010-01-01 – 2010-12-31
Current period

USD 20.4 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

20395000 − 18802000 = 1593000 USD

18802000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
20395000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · COMPLETE GENOMICS INC · 2011-12-31 COMPLETE GENOMICS INC (edgar:1361103) Year-over-year change in Capital expenditure: 1593000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 20395000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#269963 Filing: 000119312512104641 Input fundies:CapitalExpenditure: 18802000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#32386 Filing: 000119312512104641
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2011-01-01 – 2011-12-31

Revenue USD 19.34 million 100% of revenue
Operating costs Derived USD 88.64 million 458% of revenue
Operating income −USD 69.3 million −358% of revenue
Tax, interest and other Derived USD 3.05 million 16% of revenue
Net income −USD 72.35 million −374% of revenue

Cash

Operating cash flow −USD 50.51 million −261% of revenue
Capital expenditure USD 20.4 million 105% of revenue
Free cash flow Derived −USD 70.91 million −367% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Not shown: operating income or net income is not reported.
2009 Operating loss: operating costs were 5,491% of revenue.
2010 Operating loss: operating costs were 608% of revenue.
2011 Operating loss: operating costs were 458% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	0	27857000 Derived	-27857000	537000 Derived	-28394000	-31722000 Derived	Source 2008-01-01 – 2008-12-31: 0 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -27857000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -28394000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -24303000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 7419000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	623000	34208000 Derived	-33585000	2364000 Derived	-35949000	-36316000 Derived	Source 2009-01-01 – 2009-12-31: 623000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -33585000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -35949000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -26662000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 9654000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	9389000	57042000 Derived	-47653000	10034000 Derived	-57687000	-53820000 Derived	Source 2010-01-01 – 2010-12-31: 9389000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -47653000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -57687000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -35018000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 18802000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	19344000	88639000 Derived	-69295000	3053000 Derived	-72348000	-70906000 Derived	Source 2011-01-01 – 2011-12-31: 19344000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -69295000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -72348000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -50511000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 20395000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 19.3M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	0	Revenue: 0 Open source
20092009-12-31	Revenue	623000	Revenue: 623000 Open source
20102010-12-31	Revenue	9389000	Revenue: 9389000 Open source
20112011-12-31	Revenue	19344000	Revenue: 19344000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

106% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 623000 Open source Revenue: 0 Open source
20102010-12-31	Year over year	1,407.1%	Revenue: 9389000 Open source Revenue: 623000 Open source
20112011-12-31	Year over year	106%	Revenue: 19344000 Open source Revenue: 9389000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -358.2% 2011

Net margin -374% 2011

Free cash flow margin -366.6% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	Not reported	Operating Income: -27857000 Open source Revenue: 0 Open source
20092009-12-31	Operating margin	-5,390.9%	Operating Income: -33585000 Open source Revenue: 623000 Open source
20102010-12-31	Operating margin	-507.5%	Operating Income: -47653000 Open source Revenue: 9389000 Open source
20112011-12-31	Operating margin	-358.2%	Operating Income: -69295000 Open source Revenue: 19344000 Open source
20082008-12-31	Net margin	Not reported	Net Income: -28394000 Open source Revenue: 0 Open source
20092009-12-31	Net margin	-5,770.3%	Net Income: -35949000 Open source Revenue: 623000 Open source
20102010-12-31	Net margin	-614.4%	Net Income: -57687000 Open source Revenue: 9389000 Open source
20112011-12-31	Net margin	-374%	Net Income: -72348000 Open source Revenue: 19344000 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -24303000 Open source Capital Expenditure: 7419000 Open source
20092009-12-31	Free cash flow margin	-5,829.2%	Revenue: 623000 Open source Operating Cash Flow: -26662000 Open source Capital Expenditure: 9654000 Open source
20102010-12-31	Free cash flow margin	-573.2%	Revenue: 9389000 Open source Operating Cash Flow: -35018000 Open source Capital Expenditure: 18802000 Open source
20112011-12-31	Free cash flow margin	-366.6%	Revenue: 19344000 Open source Operating Cash Flow: -50511000 Open source Capital Expenditure: 20395000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -50.5M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	-24303000	Operating Cash Flow: -24303000 Open source
20092009-12-31	Operating cash flow	-26662000	Operating Cash Flow: -26662000 Open source
20102010-12-31	Operating cash flow	-35018000	Operating Cash Flow: -35018000 Open source
20112011-12-31	Operating cash flow	-50511000	Operating Cash Flow: -50511000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -70.9M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	-31722000	Operating Cash Flow: -24303000 Open source Capital Expenditure: 7419000 Open source
20092009-12-31	Free cash flow	-36316000	Operating Cash Flow: -26662000 Open source Capital Expenditure: 9654000 Open source
20102010-12-31	Free cash flow	-53820000	Operating Cash Flow: -35018000 Open source Capital Expenditure: 18802000 Open source
20112011-12-31	Free cash flow	-70906000	Operating Cash Flow: -50511000 Open source Capital Expenditure: 20395000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

36.5% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Liabilities / assets	Not reported	No source recorded
20092009-12-31	Liabilities / assets	73.1%	Total Liabilities: 22135000 Open source Total Assets: 30278000 Open source
20102010-12-31	Liabilities / assets	28.6%	Total Liabilities: 29524000 Open source Total Assets: 103160000 Open source
20112011-12-31	Liabilities / assets	36.5%	Total Liabilities: 47589000 Open source Total Assets: 130203000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.41× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Current assets / current liabilities	Not reported	No source recorded
20092009-12-31	Current assets / current liabilities	1.25×	Current Assets: 15019000 Open source Current Liabilities: 12055000 Open source
20102010-12-31	Current assets / current liabilities	4.47×	Current Assets: 79020000 Open source Current Liabilities: 17687000 Open source
20112011-12-31	Current assets / current liabilities	3.41×	Current Assets: 95165000 Open source Current Liabilities: 27888000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	−USD 28.39 million Exact value Exact value: -28394000 USD 2008-01-01 – 2008-12-31: -28394000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COMPLETE GENOMICS INC · 2008-12-31 COMPLETE GENOMICS INC (edgar:1361103) Net Income: -28394000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28394000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/0001193125-11-083079.txt#7310 The citation records this snapshot. The page link may show a newer release later.	−USD 24.3 million Exact value Exact value: -24303000 USD 2008-01-01 – 2008-12-31: -24303000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COMPLETE GENOMICS INC · 2008-12-31 COMPLETE GENOMICS INC (edgar:1361103) Operating Cash Flow: -24303000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24303000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/0001193125-11-083079.txt#7604 The citation records this snapshot. The page link may show a newer release later.	USD 7.42 million Exact value Exact value: 7419000 USD 2008-01-01 – 2008-12-31: 7419000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COMPLETE GENOMICS INC · 2008-12-31 COMPLETE GENOMICS INC (edgar:1361103) Capital Expenditure: 7419000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7419000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/0001193125-11-083079.txt#7646 The citation records this snapshot. The page link may show a newer release later.	−USD 31.72 million Calculation and evidence -24303000 − 7419000 USD Exact free cash flow: -31722000 USD 2008-01-01 – 2008-12-31: -24303000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 7419000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COMPLETE GENOMICS INC · 2008-12-31 COMPLETE GENOMICS INC (edgar:1361103) Free cash flow: -31722000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24303000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/0001193125-11-083079.txt#7604 Input fundies:CapitalExpenditure: 7419000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/0001193125-11-083079.txt#7646 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 35.95 million Exact value Exact value: -35949000 USD 2009-01-01 – 2009-12-31: -35949000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COMPLETE GENOMICS INC · 2009-12-31 COMPLETE GENOMICS INC (edgar:1361103) Net Income: -35949000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35949000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#18963 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.	−USD 26.66 million Exact value Exact value: -26662000 USD 2009-01-01 – 2009-12-31: -26662000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COMPLETE GENOMICS INC · 2009-12-31 COMPLETE GENOMICS INC (edgar:1361103) Operating Cash Flow: -26662000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26662000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#17531 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.	USD 9.65 million Exact value Exact value: 9654000 USD 2009-01-01 – 2009-12-31: 9654000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COMPLETE GENOMICS INC · 2009-12-31 COMPLETE GENOMICS INC (edgar:1361103) Capital Expenditure: 9654000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9654000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#19518 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.	−USD 36.32 million Calculation and evidence -26662000 − 9654000 USD Exact free cash flow: -36316000 USD 2009-01-01 – 2009-12-31: -26662000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 9654000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COMPLETE GENOMICS INC · 2009-12-31 COMPLETE GENOMICS INC (edgar:1361103) Free cash flow: -36316000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26662000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#17531 Filing: 000119312512104641 Input fundies:CapitalExpenditure: 9654000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#19518 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 57.69 million Exact value Exact value: -57687000 USD 2010-01-01 – 2010-12-31: -57687000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COMPLETE GENOMICS INC · 2010-12-31 COMPLETE GENOMICS INC (edgar:1361103) Net Income: -57687000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -57687000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#31499 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.	−USD 35.02 million Exact value Exact value: -35018000 USD 2010-01-01 – 2010-12-31: -35018000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COMPLETE GENOMICS INC · 2010-12-31 COMPLETE GENOMICS INC (edgar:1361103) Operating Cash Flow: -35018000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35018000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#29643 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.	USD 18.8 million Exact value Exact value: 18802000 USD 2010-01-01 – 2010-12-31: 18802000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COMPLETE GENOMICS INC · 2010-12-31 COMPLETE GENOMICS INC (edgar:1361103) Capital Expenditure: 18802000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18802000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#32386 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.	−USD 53.82 million Calculation and evidence -35018000 − 18802000 USD Exact free cash flow: -53820000 USD 2010-01-01 – 2010-12-31: -35018000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 18802000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COMPLETE GENOMICS INC · 2010-12-31 COMPLETE GENOMICS INC (edgar:1361103) Free cash flow: -53820000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35018000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#29643 Filing: 000119312512104641 Input fundies:CapitalExpenditure: 18802000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#32386 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 72.35 million Exact value Exact value: -72348000 USD 2011-01-01 – 2011-12-31: -72348000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COMPLETE GENOMICS INC · 2011-12-31 COMPLETE GENOMICS INC (edgar:1361103) Net Income: -72348000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -72348000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#177201 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.	−USD 50.51 million Exact value Exact value: -50511000 USD 2011-01-01 – 2011-12-31: -50511000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COMPLETE GENOMICS INC · 2011-12-31 COMPLETE GENOMICS INC (edgar:1361103) Operating Cash Flow: -50511000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50511000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#135413 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.	USD 20.4 million Exact value Exact value: 20395000 USD 2011-01-01 – 2011-12-31: 20395000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COMPLETE GENOMICS INC · 2011-12-31 COMPLETE GENOMICS INC (edgar:1361103) Capital Expenditure: 20395000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20395000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#269963 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.	−USD 70.91 million Calculation and evidence -50511000 − 20395000 USD Exact free cash flow: -70906000 USD 2011-01-01 – 2011-12-31: -50511000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 20395000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COMPLETE GENOMICS INC · 2011-12-31 COMPLETE GENOMICS INC (edgar:1361103) Free cash flow: -70906000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:25:17Z Snapshot: 44de753d876a4cd576c0889b5019e3cd30a74e15162df696cd14d118da61b6cd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1361103?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -50511000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#135413 Filing: 000119312512104641 Input fundies:CapitalExpenditure: 20395000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1361103/000119312512104641/gnom-20111231.xml#269963 Filing: 000119312512104641 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 634 latest values · 634 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001361103, 1361103, GNOM, edgar:1361103

Also known as COMPLETE GENOMICS INC

COMPLETE GENOMICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2011 2011-01-01 – 2011-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation